Oligohydramnios and Intrauterine Premature Closure of Ductus Arteriosus Associated with the Use of NSAIDs During Pregnancy – An Overview of Clinical Evidence
Naina Mohamed Pakkir Maideen, Sultan Al Rashid, M. Gobinath, Mohamed Harshath Jahir Hussain
{"title":"Oligohydramnios and Intrauterine Premature Closure of Ductus Arteriosus Associated with the Use of NSAIDs During Pregnancy – An Overview of Clinical Evidence","authors":"Naina Mohamed Pakkir Maideen, Sultan Al Rashid, M. Gobinath, Mohamed Harshath Jahir Hussain","doi":"10.2174/0115748855308697240409035903","DOIUrl":null,"url":null,"abstract":"\n\nPregnant women may experience low back pain and other pain symptoms,\nfever, and inflammatory conditions that may harm the fetus and mother if left untreated. The most\ncommon uses of non-steroidal anti-inflammatory drugs (NSAIDs) are the treatment of inflammation,\npain and pyrexia. However, after 20-30 weeks of gestation, using NSAIDs during pregnancy may\ncause oligohydramnios and premature ductus arteriosus closure, which could harm the developing\nfetus.\n\n\n\nThe purpose of this review article is to critically examine the clinical evidence that is\ncurrently available for oligohydramnios and premature ductus arteriosus closure linked to NSAIDs.\n\n\n\nOnline databases such as Medline/Pubmed/PMC, EBSCOhost, Scopus, Web of science,\nEmbase, Science Direct, Google Scholar, and reference lists were searched to identify articles which\ndealt with NSAIDs-associated oligohydramnios and premature closure of ductus arteriosus.\n\n\n\nNumerous regulatory agencies released warnings about oligohydramnios and premature closure\nof ductus arteriosus linked to NSAIDs. Furthermore, a number of case reports, case series, and\nsome observational studies have also been published about the possibility of oligohydramnios and\npremature closure of ductus arteriosus linked to NSAIDs use.\n\n\n\nWomen who are pregnant for 20 weeks or more should refrain from self-medicating\nwith NSAIDs without consulting a pharmacist or a physician. The use of NSAIDs during pregnancy\nshould carefully be considered due to potential risks to the mother and developing fetus, especially\nafter 20-30 weeks of gestation. To guarantee the best possible health for the expectant mother and the\nunborn child, healthcare professionals should weigh the benefits and risks and look into alternate\noptions. Pregnant women may opt for acetaminophen (paracetamol) to relieve pain and fever during\npregnancy. Pregnant women should seek medical attention if there is persisting pain for more than\nthree days.\n","PeriodicalId":11004,"journal":{"name":"Current Drug Therapy","volume":null,"pages":null},"PeriodicalIF":0.3000,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Drug Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115748855308697240409035903","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Pregnant women may experience low back pain and other pain symptoms,
fever, and inflammatory conditions that may harm the fetus and mother if left untreated. The most
common uses of non-steroidal anti-inflammatory drugs (NSAIDs) are the treatment of inflammation,
pain and pyrexia. However, after 20-30 weeks of gestation, using NSAIDs during pregnancy may
cause oligohydramnios and premature ductus arteriosus closure, which could harm the developing
fetus.
The purpose of this review article is to critically examine the clinical evidence that is
currently available for oligohydramnios and premature ductus arteriosus closure linked to NSAIDs.
Online databases such as Medline/Pubmed/PMC, EBSCOhost, Scopus, Web of science,
Embase, Science Direct, Google Scholar, and reference lists were searched to identify articles which
dealt with NSAIDs-associated oligohydramnios and premature closure of ductus arteriosus.
Numerous regulatory agencies released warnings about oligohydramnios and premature closure
of ductus arteriosus linked to NSAIDs. Furthermore, a number of case reports, case series, and
some observational studies have also been published about the possibility of oligohydramnios and
premature closure of ductus arteriosus linked to NSAIDs use.
Women who are pregnant for 20 weeks or more should refrain from self-medicating
with NSAIDs without consulting a pharmacist or a physician. The use of NSAIDs during pregnancy
should carefully be considered due to potential risks to the mother and developing fetus, especially
after 20-30 weeks of gestation. To guarantee the best possible health for the expectant mother and the
unborn child, healthcare professionals should weigh the benefits and risks and look into alternate
options. Pregnant women may opt for acetaminophen (paracetamol) to relieve pain and fever during
pregnancy. Pregnant women should seek medical attention if there is persisting pain for more than
three days.
期刊介绍:
Current Drug Therapy publishes frontier reviews of high quality on all the latest advances in drug therapy covering: new and existing drugs, therapies and medical devices. The journal is essential reading for all researchers and clinicians involved in drug therapy.